Evidence map›Paper›PMID 8623929›Full record

ArticleThe American journal of pathology1996

Induction of Heymann nephritis with a gp330/megalin fusion protein.

R Raychowdhury, G Zheng, D Brown, R T McCluskey

Abstract read
In one paragraph

Article in The American journal of pathology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Experimental Models of Membranous Nephropathy.Drug discovery today. Disease models · 2010
    Article
  9. Review
  10. Article
  11. Article
  12. Production of Heymann nephritis by a chemically modified renal antigen.International journal of experimental pathology · 2004
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The solution structure of the N-terminal domain of alpha2-macroglobulin receptor-associated protein.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  18. Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

R RaychowdhuryDepartment of Pathology, Massachusetts General Hospital, Charlestown 02129, USA.
G Zheng
D Brown
R T McCluskey

Funding

CELLULAR REGULATION OF KIDNEY EPITHELIAL CELL POLARITYR01DK042956 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 1991 to 2006
$2.2M
NIDDK NIH HHS DK-42956NIDDK NIH HHS DK-4630
6 · The paper itself

Abstract

There is considerable evidence that glomerular deposits in Heymann nephritis, a rat model of membranous nephritis, result from shedding of immune complexes formed on podocytes and that the principal antigen is part of the extracellular domain of a cell surface glycoprotein receptor called gp330 or megalin. It has also been reported that the immunogen that induces Heymann nephritis is a complex formed between gp330 and the receptor-associated protein RAP. The recent elucidation of the primary structure of gp330 makes it possible to investigate the ability of defined portions of gp330, devoid of RAP, to induce Heymann nephritis. In the present study we show that a gp330-glutathione-S-transferase fusion protein, containing 137 amino acid residues (1114 to 1250) of the ectodomain, induces active Heymann nephritis and that heterologous antibodies against this fusion protein produce passive Heymann nephritis. By immunofluorescence, typical glomerular immunoglobulin deposits were found, but complement components were lacking and the rats did not develop proteinuria. In the active model, we obtained evidence indicating that the deposits contained portions of the ectodomain of gp330, including regions other than those of the fusion protein. Thus, the deposits were stained by polyclonal antibodies to gp330 and to the gp330 fusion protein, as well as by two monoclonal antibodies reactive with portions of the ectodomain of gp330, only one of which reacted with the fusion protein in vitro. Antibodies against the cytoplasmic domain of gp330 did not stain. Furthermore, we found that RAP was able to bind to gp330 in the glomerular deposits but not to the gp330 fusion protein in vitro. The results show that the region of gp330 spanning amino acid residues 1114 to 1250 contains peptides capable of inducing pathogenic antibodies of Heymann nephritis without a contributory role of RAP.

Indexed as

Amino AcidsAnimalsAntibodiesDisease Models, AnimalEnzyme-Linked Immunosorbent AssayEpitopesFemaleFluorescent Antibody Technique, IndirectGlomerulonephritisHeymann Nephritis Antigenic ComplexKidneyMembrane GlycoproteinsRatsRats, Inbred LewAmino AcidsAntibodiesEpitopesHeymann Nephritis Antigenic ComplexMembrane Glycoproteins

Identifiers

PMID8623929
PMCPMC1861581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.